Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Developments in cell therapy in the year 2000].

L Douay1

  • 1Service d'hématologie biologique, Hôpital d'enfants Armand-Trousseau, Paris, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|February 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Leukemia·2016
Same author

A novel micronucleus in vitro assay utilizing human hematopoietic stem cells.

Toxicology in vitro : an international journal published in association with BIBRA·2015
Same author

Modulation of pathological phenotype of red blood cells generated ex vivo from hematopoietic stem cells in patients with sickle cell disease.

Journal of stem cells & regenerative medicine·2014
Same author

JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

Leukemia·2013
Same author

[Red blood cell production for transfusion purposes. A stem cell ex vivo fate].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2013
Same author

Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia.

Leukemia·2009
Same journal

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Catastrophic CD34+ autologous hematopoietic stem cell collection despite sustained mobilization and solutions to rescue the harvests.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Title of the study: Corrected Count Increment as a Predictor of Early Graft Dysfunction and Mortality Following Living Donor Liver Transplantation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

TLR4/MD-2 complex promotes transfusion-related acute lung injury pathogenesis through the activation of the AP-1 and NF-κB signaling pathways.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

The Strategic Utility of Cryopreserved Platelets in Outer Space.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
Same journal

Genotyping of Human Neutrophil Antigen-3 by High Resolution Melting Analysis in Southern Thai Blood Donors.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2026
See all related articles

Hematopoietic stem cell (HSC) transplantation has evolved significantly, shifting towards immunotherapy and ex vivo expansion. Recent discoveries show differentiated cells can regain totipotency, advancing cellular engineering.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Immunotherapy

Context:

  • Evolution of hematopoietic stem cell (HSC) transplantation over 30 years.
  • Shift from bone marrow transplantation to HSC transplantation, allograft to autograft, and non-manipulated to hyper-selected grafts.
  • Increasing clarity in indications for malignant and autoimmune diseases.

Purpose:

  • To highlight the paradigm shift in hematology towards HSC transplantation and immunotherapy.
  • To discuss advancements in controlling HSC proliferation and differentiation for ex vivo expansion.
  • To introduce the concept of cellular totipotency in differentiated cells and its implications.

Summary:

  • Hematology has transitioned from bone marrow transplantation to hematopoietic stem cell (HSC) transplantation, embracing autografts, hyper-selection, and immunotherapy.

Related Experiment Videos

  • Enhanced understanding of HSCs enables control over their proliferation and differentiation, facilitating ex vivo expansion.
  • Recent findings demonstrate differentiated cells, like neural cells, can regain totipotency, yielding HSCs, mesenchymal cells, or hepatocytes.

    • Impact:

    • Advances in HSC transplantation for malignant and autoimmune diseases.
    • Opening new avenues for ex vivo HSC expansion and cellular engineering.
    • Potential for regenerative medicine through cellular totipotency and advanced biomaterials.